Search results
People Spent the Most Money on These 25 Prescription Drugs Last Year
Healthline via AOL· 13 hours agoA new study found that spending on prescription drugs in the U.S. has skyrocketed in the last year....
FTC warns pharma companies it means business with its Orange Book listing policy | JD Supra
JD Supra· 2 days agoLast September, the Federal Trade Commission (FTC) promulgated a “policy statement” entitled “Statement Concerning Brand Drug Manufacturers’ Improper Listing of Patents in ...
Flightpath Biosciences BizSpotlight - Boston Business Journal
The Business Journals· 7 days agoFlightpath Biosciences Inc., a clinical-stage life sciences company announced today that the first healthy volunteers have been dosed in its Phase I...trial of FP-100 (hygromycin ...
Large and Unjustified: Second Circuit Clarifies Pleading Requirements in Reverse Payments Cases | JD...
JD Supra· 18 hours agoCourt case on reverse payment settlements—the Second Circuit for the first time weighed in on whether (and how) antitrust plaintiffs’ identification of a so-called "side deal" between a patent ...
Earnings call: Paysign reports strong Q1 growth, optimistic outlook
Investing.com· 5 days agoPaysign Inc. (PAYS) has announced a significant increase in its financial performance for the first...
Top Stock Reports for Broadcom, Merck & Airbnb
Zacks· 2 days ago(AVGO), Merck & Co., Inc. (MRK) and Airbnb, Inc. (ABNB). Broadcom shares have outperformed the Zacks Electronics - Semiconductors industry over the year-to-date period (+24.2% vs. +13.0%) on ...
Royalty Pharma PLC (RPRX): A Strategic SWOT Insight
Guru Focus· 7 days agoOn May 9, 2024, Royalty Pharma PLC (RPRX, Financial), the largest buyer of biopharmaceutical royalties, filed its 10-Q report, revealing a nuanced financial landscape. The company< ...
The Zacks Analyst Blog Highlights Broadcom, Merck, Airbnb, ONEOK and PG&E
Zacks via Yahoo Finance· 14 hours agoThe company beat Q1 estimates for earnings and sales. Products like Keytruda and Gardasil...growth....
Narendra Modi’s flagship growth scheme is off to a sluggish start
The Economist· 15 hours agoIn the early 1990s India abandoned the principles of swadeshi, or self-sufficiency, that had guided...
Cancer Drug Price-Cutting Pitch Mulled by HHS as Industry Waits
Bloomberg Law· 7 days agoThe Biden administration is weighing a drug pricing control proposition that attorneys and industry watchers say could bolster efforts to lower prescription costs even if ...
